Perfect for use around the eye area or general facial use
Managing common side effects Like other weight loss medications, tirzepatide can also cause mild to moderate gastrointestinal side effects such as nausea (most common), diarrhea, and constipation, especially during the start of treatment or when the dose is increased
Peptide drug treatment Mice were treated via subcutaneous (s.c.) injection at the indicated doses with either long-acting acyl-GIP (100 nmol kg 1 s.c.), LIRA (100 nmol kg 1 s.c.) or an acylated peptide GIPR antagonist ([N-Ac,L14,R18,E21]hGIP(531)-K11(E-C16)) (1500 nmol kg 1 s.c.)
However, BPC-157 is not approved for human use by any regulatory agency, and its safety remains largely unproven
The Outer Thigh (Vastus Lateralis Muscle) Another excellent option is the outer thigh